IGF Replacement Therapy for Diabetic Neuropathy
Author Information
Author(s): Douglas N. Ishii, Sean B. Lupien
Primary Institution: Colorado State University
Hypothesis
A decline in insulin-like growth factor (IGF) activity contributes to the pathogenesis of diabetic neuropathy.
Conclusion
IGF replacement therapy can prevent or reverse neurological disturbances in diabetic patients, independent of glycemic control.
Supporting Evidence
- IGF treatment can prevent hyperalgesia in diabetic rats.
- IGF administration can reverse impaired nerve regeneration.
- IGF-I treatment normalizes cognitive function in diabetic rats.
Takeaway
This study shows that giving IGF can help fix nerve problems in people with diabetes, even if their blood sugar is high.
Methodology
The study involved biochemical and electrophysiological measurements in diabetic rat models to assess the effects of IGF treatment on nerve regeneration and function.
Limitations
The study primarily uses animal models, which may not fully replicate human conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website